
The Risk of High CNI Exposure
Reduce CNI-related Toxicities in post-transplant patients with Certican®


Abbreviations:
CNI, Calcineurin inhibitors; NODAT, New-onset diabetes after transplantation; BP, blood pressure; GFR, glomerular filtration rate; CsA, cyclosporin;
KDIGO, Kidney Disease: Improving Global Outcomes
References:
1. Farouk SS, et al.Adv Chronic Kidney Dis. 2020;27(1):56-66. 2. Noble J, et al.Best Pract Res Clin Gastroenterol . 2021;54-55:101762. 3. Ruggenenti P, et al. Kidney Int. 1993;43(3):706-711. 4. Robert N, et al. Cochrane Database Syst Rev. 2010;(1):CD007893. 5. Veroux M, et al. Clin Dev Immunol. 2013;2013:496974. 6. Rovin BH, et al.Kidney Int. 2021;100(4):753-779. 7. Sawinski D, et al. Am J Transplant. 2016;16(7):2117-2138. 8. Farkas SA, et al.Transpl Int. 2009;22(1):49-60. 9. Cibrik D, et al. Transplantation. 2013;95(7):933–942. 10.Pascual J, et al. J Am Soc Nephrol. 2018;29(7):1979-1991. 11. Mao B, et al. Molecules. 2022;27(16):5295.

20 Pasir Panjang Road #10-25/28 Mapletree Business City (West Tower) Singapore 117439
Phone: +65 6722 6010
This content is not for local distribution. This should be modified to accommodate local guidance before local distribution.
FOR HEALTHCARE PROFESSIONALS ONLY
Please visit https://www.novartis.com/sg-en/product-list/certican to access or download the Package Insert.
Alternatively, please scan this code for more Information about this medicine.

FA-11484250_2027Aug05